The Provincial Government thru the Provincial Agriculture Office and the Department of Agriculture Region 8 – Agribusiness and Marketing Assistance Division (DA-AMAD) meets agri-entrepreneurs today, February 23, 2022, at the Provincial Library, New Capitol Building, for the second day of the Enterprise Development Assessment.

The activity, aimed to help sustain agri-business operations in the province, started with an enterprise assessment where producers were made to identify the issues and concerns in their respective ventures; assess the Strengths, Weaknesses, Opportunities and Threats (SWOT) of their enterprise; and develop a Three-Year Capacity Development Plan. It also sought to assess the organizational structure and administration of the association, to include policies implemented & systems of operation; marketing and financial aspect, as well as the sustainability of their enterprise.

Spearheaded by the DA-AMAD under the Republic Act 11321 or the Sagip Saka Act, the activity is part of the priority agenda of Governor Edwin Ongchuan dubbed as ‘Sustained PROGRESS,’ under “P’ for Pro-Poor Programs and Agro-Industrial Development.

The said program is a three-day activity attended by Washington Farmers Association during the first day of assessment held on February 22. Second day participants were the Association of Northern Samar Provincial Federation held today, February 23. On the last day (February 24), target participants are the members of Nenita Farmers Association and Polangi Farmers Association.

Present were PAO officials headed by Mr. Lorenzo Mahinay represented by Ms. Emma Opog, and the DA-AMAD 8 team headed by Ms. Brenda Vacalares.

#AgriBusinessDevelopment

#FoodSustainability

#PadayonNgaKauswagan

#NortehanonMarigonMainuswagonMalipayon

 

Pio Nsamar

Northern Samar Agriculture Office

Department of Agriculture – Eastern Visayas

Ceci est une note amicale qui fournit des informations sur la proprepharmacie.com pharmacie en France. Elle donne des détails sur votre pharmacie locale ainsi que sur les médicaments les plus courants en France par rapport aux États-Unis.